ArticleCancer immunology, immunotherapy : CII2013

Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy.

Ashley J Knights et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.